Insider Transactions in Q2 2024 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.66%
|
$386,900
$53.73 P/Share
|
|
Jun 25
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.69%
|
$37,100
$7.96 P/Share
|
|
Jun 17
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$260,000
$52.55 P/Share
|
|
Jun 17
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$50,000
$10.68 P/Share
|
|
Jun 17
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
22,500
-2.6%
|
$1,170,000
$52.59 P/Share
|
|
Jun 11
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,788
-2.76%
|
$412,764
$53.04 P/Share
|
|
Jun 11
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,422
+3.66%
|
$37,954
$7.96 P/Share
|
|
Jun 10
2024
|
Muna Bhanji Director |
SELL
Open market or private sale
|
Direct |
2,000
-10.19%
|
$104,000
$52.07 P/Share
|
|
Jun 04
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
22,500
-4.87%
|
$1,080,000
$48.85 P/Share
|
|
Jun 03
2024
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
1,580
-9.23%
|
$75,840
$48.64 P/Share
|
|
Jun 03
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-24.27%
|
$240,000
$48.64 P/Share
|
|
Jun 03
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+19.53%
|
$50,000
$10.68 P/Share
|
|
Jun 03
2024
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
13,011
-43.86%
|
$624,528
$48.88 P/Share
|
|
May 31
2024
|
Sung Lee EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,684
+50.0%
|
-
|
|
May 15
2024
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+22.19%
|
-
|
|
May 15
2024
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+24.65%
|
-
|
|
May 15
2024
|
Santo J Costa Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+21.37%
|
-
|
|
May 15
2024
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+19.75%
|
-
|
|
May 15
2024
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+18.71%
|
-
|
|
May 15
2024
|
B Lynne Parshall Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+21.37%
|
-
|
|
May 15
2024
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+18.35%
|
-
|
|
May 15
2024
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+12.94%
|
-
|
|
May 07
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
15,547
-5.14%
|
$1,010,555
$65.11 P/Share
|
|
May 07
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
14,186
+8.51%
|
$85,116
$6.67 P/Share
|
|
Apr 25
2024
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
10,562
-24.77%
|
$675,968
$64.54 P/Share
|
|
Apr 12
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Bona fide gift
|
Direct |
150
-0.11%
|
-
|
|
Apr 09
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
32,605
-9.76%
|
$2,412,770
$74.31 P/Share
|
|
Apr 09
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
28,605
+14.32%
|
$171,630
$6.67 P/Share
|